Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Leucine-rich repeat-containing protein 69 (LRRC69) is a human protein encoded by the LRRC69 gene located on chromosome 8[1][2][10]. It is classified as a protein-coding gene, and participates in the broader family of leucine-rich repeat-containing proteins, which often serve scaffolding or adaptor roles in protein-protein interactions[2][4][6]. Predicted function involves participation in intracellular signal transduction based on gene ontology and related resources, but no experimentally defined and specific role or pathway has been established for the human protein[1][3]. The gene has an important paralog, ERBIN[1]. There is no current evidence to define LRRC69 as a therapeutic target, receptor, enzyme, transporter, or biomarker for disease nor any described drug interactions or safety considerations associated with modulation of this protein in the available literature[1][6][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leucine-rich repeat-containing protein 69 (LRRC69).